 Jaekyu Shin, PharmD
|
|
| Title(s) | Professor, Clinical Pharmacy |
|---|
| School | School of Pharmacy |
|---|
| Phone | 415-514-2747 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of Florida | Fellowship Cardiovascular Pharmacogenomics | 2007 | | | University of Miami Jackson Memorial Hospital | Pharmacy Practice Residency | 2004 | | | University of Florida | PharmD | 2003 | | | Seoul National University | MS Pharmacology | 1996 | | | Seoul National University | BS Pharmacy | 1994 | |
Bibliographic
-
Chang MT, McCarthy JJ, Shin J. Clinical application of pharmacogenetics: focusing on practical issues. Pharmacogenomics. 2015; 16(15):1733-41. PMID: 26411302.
-
Cao DX, Kohatsu A, Eng L, Mei K, Dinh J, Mok I, Moreau N, Le A, Shin J. Evaluation of initial dofetilide dosing recommendation based on actual body weight in overweight and obese patients. J Clin Pharm Ther. 2015 Dec; 40(6):635-9. PMID: 26365492.
-
Shin-Yi Lin, Lynn V. Do, Steve R. Kayser, Jaekyu Shin.Use Patterns and Unlabeled Uses of Target Specific Oral Anticoagulants: A Single Center Experience. J Pharm Technol. 2015.
-
Cheng CM, Shin J, Guglielmo BJ. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA Intern Med. 2014 Oct; 174(10):1704-5. PMID: 25127107.
-
Shin J, Pletcher MJ. Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice. Am J Med. 2013 Sep; 126(9):805-810.e5. PMID: 23968902.
-
Shin J, Gonzales M, Pletcher MJ. Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. Pharmacotherapy. 2013 Dec; 33(12):1353-61. PMID: 23813768; PMCID: PMC3797244.
-
Jaekyu Shin, Su-Ying Liang, Michael J. Hassett, Kathryn A. Phillips, Jennifer S. Haas.Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab. Personalized Medicine. 2013; 10:703-708.
-
Huang C, Siu M, Vu L, Wong S, Shin J. Factors influencing doctors' selection of dabigatran in non-valvular atrial fibrillation. J Eval Clin Pract. 2013 Oct; 19(5):938-43. PMID: 22834964.
-
Cavallari LH, Shin J, Perera MA. Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy. 2011 Dec; 31(12):1192-207. PMID: 22122181; PMCID: PMC3655546.
-
Shin J, Pauly DF, Pacanowski MA, Langaee T, Frye RF, Johnson JA. Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin. Pharmacotherapy. 2011 Oct; 31(10):942-50. PMID: 21950641; PMCID: PMC3712822.
-
Shin J, Kayser SR. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort. Pharmacotherapy. 2011 Sep; 31(9):863-70. PMID: 21923587.
-
Shin J, Cao D. Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort. Pharmacogenomics. 2011 Jan; 12(1):125-34. PMID: 21174627.
-
Litonjua AA, Gong L, Duan QL, Shin J, Moore MJ, Weiss ST, Johnson JA, Klein TE, Altman RB. Very important pharmacogene summary ADRB2. Pharmacogenet Genomics. 2010 Jan; 20(1):64-9. PMID: 19927042; PMCID: PMC3098753.
-
Kadafour M, Haugh R, Posin M, Kayser SR, Shin J. Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics. 2009 Nov; 10(11):1853-60. PMID: 19891559.
-
Ikediobi ON, Shin J, Nussbaum RL, Phillips KA, Walsh JM, Ladabaum U, Marshall D. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009 Jul; 86(1):28-31. PMID: 19536122; PMCID: PMC2910521.
-
Shin J, Kayser SR, Langaee TY. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm. 2009 Apr 01; 66(7):625-37. PMID: 19299369.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|